As a member of the Center for Vector-Borne Infectious Diseases (CVID) at Colorado State University, the Foy laboratory focuses on the interactions of vectors with their hosts and with vector pathogens. The goal is to link research employing molecular, proteomic and genomic techniques to practical applications for controlling arthropod-borne diseases. A main research component in the Foy lab is to interrupt the intense transmission of malaria and arboviruses by targeting the vector through their bloodmeals using drugs that attack vector physiology and that inhibit pathogen development or using anti-vector immunity driven by vaccination. The Foy lab is also developing mosquitoes and other vectors as biosurveillance tools, studying unique aspects of arbovirus transmission and arbovirus survival in vectors, and studying poorly understood mosquito pathogens for their prospects to become vector-borne disease control tools.
People
news and updates view all
Brian Foy has been studying ivermectin for nearly a decade, long before it became a hot topic in the United States.
Lyndsey Gray, an MIP PhD candidate, is one of two CSU graduate students to receive a prestigious PEO Scholar Award for their outstanding scholarship and contributions to mentoring.
Brian Foy and Tony Schountz from the Center of Vector-Borne Infectious Diseases discussed the science behind animal-to-human transmission of infectious diseases and how COVID-19 has played out thus far.
contact information
Office: Center for Vector-Borne Infectious Diseases room 168
(970) 491-3470
brian.foy@colostate.edu